Company / Debt per Share
Inmune Bio, Inc. Debt per Share History
FY2021-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.11
FY2021
5-year range
$1.11 / $1.11
FY2021-FY2021
Trend
-
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
1.11 in FY2021.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $1.11 | - |
| FY2020 | - | - |
| FY2018 | - | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026